Splinting to Treat Hand Osteoarthritis (SPLINTOA)
Primary Purpose
Hand Osteoarthritis
Status
Completed
Phase
Phase 2
Locations
United Kingdom
Study Type
Interventional
Intervention
Splinting
Sponsored by

About this trial
This is an interventional treatment trial for Hand Osteoarthritis focused on measuring Hand, osteoarthritis, splint, pain, deformity, function
Eligibility Criteria
Inclusion Criteria:
- Aged 18 - 90
- Definite diagnosis of IPJ osteoarthritis (American College of Rheumatology criteria for OA)
- A previous radiograph of the hands with changes consistent with OA
- Either, Intervention group: At least 2 'affected' IPJs (symptomatic (>2/10 average pain on 0-10 scale in past week) and radiological OA associated with 10 degrees of either radial or ulnar deviation of the joint evident clinically and on Xray)
- OR Control group: At least 1 'affected' IPJ (symptomatic (>2/10 average pain on 0-10 scale in past week) and radiological OA associated with 10 degrees of either radial or ulnar deviation of the joint evident clinically and on X-ray)
- Stable oral therapy for month prior to study entry e.g. non steroidal anti-inflammatory drugs (NSAIDs)
- Capable of providing written informed consent
Exclusion Criteria:
- Contraindication to splinting e.g. allergy to materials
- Planned surgery during study period
- Oral, intramuscular or intraarticular steroids within 3 months of study entry
- Intraarticular hyaluronans to any nominated IP joints within 6 months of study entry
- Not resident in UK
- Pregnancy
- Other inflammatory arthritis
- History of psoriasis
- Participation in other intervention trials
- Patients with any uncontrolled or severe medical problems which in the opinion of the investigator makes them unsuitable for study participation
- Unable to give informed written consent in English
Sites / Locations
- Imperial College Healthcare NHS Trust
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intervention (splinting)
Control
Arm Description
Splinting of nominated joint in this group
Observation and usual treatment only.
Outcomes
Primary Outcome Measures
Pain in nominated joint
Assessed via numerical rating scale
Secondary Outcome Measures
Radiological deviation of nominated joint
Degrees of radial or ulnar deviation of joint will be assessed radiographically.
Full Information
NCT ID
NCT01249391
First Posted
November 25, 2010
Last Updated
February 15, 2016
Sponsor
Imperial College London
Collaborators
National Institute for Health Research, United Kingdom
1. Study Identification
Unique Protocol Identification Number
NCT01249391
Brief Title
Splinting to Treat Hand Osteoarthritis
Acronym
SPLINTOA
Official Title
Splinting to Treat Interphalangeal Joint Deformity in Hand Osteoarthritis(Splint OA Study)
Study Type
Interventional
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
September 2010 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
December 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Imperial College London
Collaborators
National Institute for Health Research, United Kingdom
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Osteoarthritis (OA) is the most common form of arthritis and the hand is the most frequently affected site.Interphalangeal (IP) joints (the small joints of the fingers) are often involved causing pain, progressive loss of hand function and deformity. Deviation, or bending to the side, of IP joints (IPJs) with significant functional and cosmetic consequences for the individual is common. There are no drugs which can slow the disease process so there is reliance on symptomatic treatment such as pain relief and hand therapy. Joint thermoplastic splinting (moulded plastic splints that are custom-made) is employed by hand therapists in other settings, but to the investigators knowledge no studies have formally investigated the effect of splinting in IP OA.
By resting inflamed tissues and correcting joint alignment, a beneficial role for splinting in IP OA is likely. In this study, the investigators want to test whether thermoplastic splinting of deviated IP joints due to OA will 1) improve joint alignment 2) ameliorate soft tissue inflammation, and whether as a consequence 3) pain and overall hand function will be improved.
Adults with hand OA with 'affected' IP joints (symptoms from OA associated with deviation of the joint on X-ray)will be recruited from a specialist hand osteoarthritis clinic. Initially this will be for distal IP (DIP) joints. In the intervention group (30 patients), an 'intervention' joint for splinting will be identified as the most painful deviated DIP joint in the past week leading up to enrolment. Up to 3 other 'affected' DIP joints on either hand will not be splinted but will be monitored as 'control' joints. In the control group (15 patients), an affected joint will be monitored but not splinted. Assessment of joint pain, hand function by a hand therapist, deformity (by X-ray)and joint inflammation will take place at baseline, during and at the end of splinting period of 3 months, and also at 6 months,to assess whether any changes are persistent. In this way, the efficacy of splinting of IP joints in OA will be assessed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hand Osteoarthritis
Keywords
Hand, osteoarthritis, splint, pain, deformity, function
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention (splinting)
Arm Type
Active Comparator
Arm Description
Splinting of nominated joint in this group
Arm Title
Control
Arm Type
No Intervention
Arm Description
Observation and usual treatment only.
Intervention Type
Device
Intervention Name(s)
Splinting
Intervention Description
Gutter thermoplastic custom-made splint for nominated joint, to be worn at night-time for consecutive nights for 3 months
Primary Outcome Measure Information:
Title
Pain in nominated joint
Description
Assessed via numerical rating scale
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Radiological deviation of nominated joint
Description
Degrees of radial or ulnar deviation of joint will be assessed radiographically.
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged 18 - 90
Definite diagnosis of IPJ osteoarthritis (American College of Rheumatology criteria for OA)
A previous radiograph of the hands with changes consistent with OA
Either, Intervention group: At least 2 'affected' IPJs (symptomatic (>2/10 average pain on 0-10 scale in past week) and radiological OA associated with 10 degrees of either radial or ulnar deviation of the joint evident clinically and on Xray)
OR Control group: At least 1 'affected' IPJ (symptomatic (>2/10 average pain on 0-10 scale in past week) and radiological OA associated with 10 degrees of either radial or ulnar deviation of the joint evident clinically and on X-ray)
Stable oral therapy for month prior to study entry e.g. non steroidal anti-inflammatory drugs (NSAIDs)
Capable of providing written informed consent
Exclusion Criteria:
Contraindication to splinting e.g. allergy to materials
Planned surgery during study period
Oral, intramuscular or intraarticular steroids within 3 months of study entry
Intraarticular hyaluronans to any nominated IP joints within 6 months of study entry
Not resident in UK
Pregnancy
Other inflammatory arthritis
History of psoriasis
Participation in other intervention trials
Patients with any uncontrolled or severe medical problems which in the opinion of the investigator makes them unsuitable for study participation
Unable to give informed written consent in English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fiona Watt
Organizational Affiliation
Imperial College London
Official's Role
Principal Investigator
Facility Information:
Facility Name
Imperial College Healthcare NHS Trust
City
London
Country
United Kingdom
12. IPD Sharing Statement
Citations:
PubMed Identifier
24509405
Citation
Watt FE, Kennedy DL, Carlisle KE, Freidin AJ, Szydlo RM, Honeyfield L, Satchithananda K, Vincent TL. Night-time immobilization of the distal interphalangeal joint reduces pain and extension deformity in hand osteoarthritis. Rheumatology (Oxford). 2014 Jun;53(6):1142-9. doi: 10.1093/rheumatology/ket455. Epub 2014 Feb 8.
Results Reference
derived
Learn more about this trial
Splinting to Treat Hand Osteoarthritis
We'll reach out to this number within 24 hrs